Neoprobe starts phase III trial

Gamma camera probe developer Neoprobe has launched a phase III clinical trial for its Lymphoseek radiopharmaceutical agent.

The study will evaluate the efficacy of Lymphoseek in identifying lymph nodes that may be predictive of determining whether a patient's cancer has spread into the lymphatic system, according to the Dublin, OH-based vendor.

Related Reading

Neoprobe gets OK for Lymphoseek study, April 16, 2008

Neoprobe announces phase II Lymphoseek results, March 13, 2008

Neoprobe nets financing, December 27, 2007

Neoprobe extends agreement with Ethicon, December 20, 2007

Neoprobe, Cardinal Health ink distribution deal, November 28, 2007

Copyright © 2008

Page 1 of 436
Next Page